These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22139535)

  • 1. Sustained cytoplasmic delivery and anti-viral effect of PLGA nanoparticles carrying a nucleic acid-hydrolyzing monoclonal antibody.
    Joung YK; Son S; Jang JY; Kwon MH; Park KD
    Pharm Res; 2012 Apr; 29(4):932-42. PubMed ID: 22139535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized stability retention of a monoclonal antibody in the PLGA nanoparticles.
    Son S; Lee WR; Joung YK; Kwon MH; Kim YS; Park KD
    Int J Pharm; 2009 Feb; 368(1-2):178-85. PubMed ID: 18996459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of METase-pemetrexed-loaded PEG-PLGA nanoparticles modified with anti-CD133-scFV for treatment of gastric carcinoma.
    Xin L; Zhang HT; Yang WF; Li YF; Liu C
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29229675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional stability of 3D8 scFv, a nucleic acid-hydrolyzing single chain antibody, under different biochemical and physical conditions.
    Lee J; Park H; Kim M; Seo Y; Lee Y; Byun SJ; Lee S; Kwon MH
    Int J Pharm; 2015 Dec; 496(2):561-70. PubMed ID: 26536531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
    Nair K L; Jagadeeshan S; Nair SA; Kumar GS
    Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery.
    Vasconcelos A; Vega E; Pérez Y; Gómara MJ; García ML; Haro I
    Int J Nanomedicine; 2015; 10():609-31. PubMed ID: 25670897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin.
    Yang T; Nyiawung D; Silber A; Hao J; Lai L; Bai S
    AAPS PharmSciTech; 2012 Dec; 13(4):1309-18. PubMed ID: 23054983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spermidine-mediated poly(lactic-
    Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
    Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule delivery to solid tumors with chitosan-coated PLGA particles: A lesson learned from comparative imaging.
    Park J; Pei Y; Hyun H; Castanares MA; Collins DS; Yeo Y
    J Control Release; 2017 Dec; 268():407-415. PubMed ID: 29111150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL/6 mice.
    Lee G; Yu J; Cho S; Byun SJ; Kim DH; Lee TK; Kwon MH; Lee S
    PLoS Pathog; 2014 Jun; 10(6):e1004208. PubMed ID: 24968358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of antitumor activities of trastuzumab delivered by PLGA nanoparticles.
    Colzani B; Pandolfi L; Hoti A; Iovene PA; Natalello A; Avvakumova S; Colombo M; Prosperi D
    Int J Nanomedicine; 2018; 13():957-973. PubMed ID: 29491709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
    Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
    Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of teniposide PLGA nanoparticles and their uptake in human glioblastoma U87MG cells.
    Mo L; Hou L; Guo D; Xiao X; Mao P; Yang X
    Int J Pharm; 2012 Oct; 436(1-2):815-24. PubMed ID: 22846410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity.
    Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C
    Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization and uptake of PEG-coated, muco-inert nanoparticles in HGC-27 cells, a mucin-producing, gastric-cancer cell line.
    Lin D; Li G; Qin L; Wen Z; Wang J; Sun X
    J Biomed Nanotechnol; 2013 Dec; 9(12):2017-23. PubMed ID: 24266257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.